Actively Recruiting
Enhancement of Quality of Work And Life
Led by Radboud University Medical Center · Updated on 2025-05-29
124
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
Sponsors
R
Radboud University Medical Center
Lead Sponsor
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Work participation is essential for quality of life, providing purpose, social interaction, financial security, and shaping social status. Work participation is increasingly compromised in people with slowly progressive chronic disorders (hereafter referred to as progressive disorders). This negatively impacts their quality of life. Early work-related support, focused on sustainable work-retention, has the potential to enhance work participation in people with progressive disorders. Therefore, this study investigates the (cost)effectiveness of the Preventive Participatory Workplace Intervention (PPWI), a personalized work intervention to enhance sustainable work participation. The investigators perform an 18-month randomized controlled trial (RCT). In addition, the investigators perform a process evaluation and an economic evaluation alongside the RCT. 124 Dutch working persons with three types of movement disorders will be included: Parkinson's Disease (PD), cerebellar ataxia (CA) and hereditary spastic paraparesis (HSP) and with slowly progressive neuromuscular and mitochondrial disorders.
CONDITIONS
Official Title
Enhancement of Quality of Work And Life
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Parkinson Disease, cerebellar ataxia, hereditary spastic paraparesis, or a slowly progressive neuromuscular or mitochondrial disorder confirmed by a treating physician
- Aged between 18 and 65 years
- Employed for at least 8 hours per week at the start of the study
- Intend to continue working during the 18-month study period
- Willing to talk to employer or manager about work performance changes (disclosing diagnosis not required)
You will not qualify if you...
- Beginning a sick leave procedure under the Gatekeeper Improvement Act
- Fully self-employed without paid employment
- Employed by a second employer for more than eight hours per week
- Insufficient proficiency in the Dutch language
- Severe health issues or comorbidities that prevent following the study protocol, such as severe cognitive impairment, rapid disease progression, or planned surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 GA
Actively Recruiting
Research Team
P
Pauline van Barschot
CONTACT
E
Elbrich Postma, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here